Boisar Facility Successfully Renews EU-GMP Certification

Boisar Facility Successfully Renews EU-GMP Certification

Mac-Chem Products Boisar facility successfully renews EU-GMP certification

Overview

Mac-Chem Products (India) Pvt. Ltd. (Mac-Chem) announced the successful renewal of its European Union Goods Manufacturing Practices (EU-GMP) certification for its manufacturing facility in Boisar. The approval marks a significant milestone for Mac-Chem in its journey of global leadership. The audit was conducted in October 2023 by Swissmedic Swiss Agency for Therapeutic Products. 

Words from Mac-Chem 

Speaking on the development, Manish Jain, director at Mac-Chem said, “We are delighted with the successful renewal of our EU-GMP certification. The achievement affirms our commitment to the highest standards of quality and compliance aligning with the European regulations. The timely approval further reaffirms our commitment for delivering high-quality pharma products that positively impact patient care globally. 

EU-GMP Certification

  • The EU-GMP certification underlines the Boisar facility’s capabilities to ensure consistent and controlled production in accordance with EU quality standards. 
  • The facility produces a wide range of APIs, with a special focus on oncology and other niche specialty segments. 

About Mac-Chem

  • Mac-Chem Products (India) Pvt. Ltd. (Mac-Chem) is a leading pharmaceutical company with a strong presence in active pharmaceutical ingredients (APIs). 
  • Headquartered in Mumbai, the company has operations in over 40 countries globally. 
  • A subsidiary of Naprod Life Sciences, Mac-Chem was established in 2010 to address the uncertainty related to the availability and quality of APIs. 
  • With over 800 employees, Mac-Chem now has a national and a global footprint with four facilities which hold accreditations from multiple regulatory bodies including the US FDA, EDQM, COFEPRIS, ANVISA, MFDS-Korea, WHO-GMP, Written Confirmation (WC) and ISO.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!